Global Patent Index - EP 1105144 A1

EP 1105144 A1 20010613 - COMPOSITION AND METHOD FOR ELIMINATING UNDIGESTED FAT AND REDUCING CHOLESTEROL IN THE HUMAN BODY

Title (en)

COMPOSITION AND METHOD FOR ELIMINATING UNDIGESTED FAT AND REDUCING CHOLESTEROL IN THE HUMAN BODY

Title (de)

ZUSAMMENSETZUNG UND METHODE ZUR ENTFERNUNG UNVERDAUTER FETTE UND ZUR CHOLESTERINSENKUNG IM MENSCHLICHEN KÖRPER

Title (fr)

COMPOSITION ET PROCEDE POUR L'ELIMINATION DES LIPIDES NON DIGERES ET LA REDUCTION DU CHOLESTEROL DANS LE CORPS HUMAIN

Publication

EP 1105144 A1 20010613 (EN)

Application

EP 98943227 A 19980818

Priority

US 9817074 W 19980818

Abstract (en)

[origin: MXPA01001802A] A moisture activated composition is provided for ingestion by humans to aid in absorbing and binding undigested fat for rapid elimination from the human body. In a first preferred embodiment the composition comprises at least one fibrous agent, such as psyllium, in an amount of generally about 80 % by weight of the composition, an amount of glucosamine HCL generally about 10 % by weight of the composition, and amount of glucomannan, apple pectin, and stearic acid forming the other generally about 10 % by weight of the composition. In an alternative embodiment intended to achieve more rapid weight loss, the composition comprises a mixture of an amount of at least one fibrous agent, such as psyllium, at generally between 50 % by weight, an amount of glucosamine HCL at generally between 40 % by weight, an amount of glucomannan generally between 5 % and 6 % by weight, an amount of fruit or vegetable derived pectin such as apple pectin generally about 2 % by weight and an amount of stearic acid generally between 1 % and 2 % by weight of the composition. Finally, in an alternative embodiment, intended more for reducing cholesterol, the chemical composition preferably comprises at least one fibrous agent, such as psyllium, in an amount of generally about 85 % by weight of the composition, an amount of glucosamine HCL generally about 6 % by weight of the composition, and amounts of glucomannan, apple pectin, and stearic acid forming the other generally about 10 % by weight of the composition.

IPC 1-7

A61K 35/78

IPC 8 full level

A61K 9/48 (2006.01); A23L 1/308 (2006.01); A23L 29/231 (2016.01); A23L 29/238 (2016.01); A23L 29/244 (2016.01); A23L 29/275 (2016.01); A61K 31/20 (2006.01); A61K 31/70 (2006.01); A61K 31/715 (2006.01); A61K 31/716 (2006.01); A61K 31/722 (2006.01); A61K 31/732 (2006.01); A61K 31/736 (2006.01); A61K 36/00 (2006.01); A61K 36/73 (2006.01); A61K 39/385 (2006.01); A61P 1/00 (2006.01); A61P 3/00 (2006.01)

IPC 8 main group level

A61K (2006.01); A61P (2006.01)

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

EP 1105144 A1 20010613; EP 1105144 A4 20030521; HK 1040630 A1 20020621; HK 1040630 B 20050422; JP 2002523373 A 20020730; MX PA01001802 A 20020408

DOCDB simple family (application)

EP 98943227 A 19980818; HK 02102239 A 20020325; JP 2000565906 A 19980818; MX PA01001802 A 19980818